183 related articles for article (PubMed ID: 26148319)
1. A Qualitative Study Exploring the Perceptions of Sedentary Behavior in Prostate Cancer Survivors Receiving Androgen-Deprivation Therapy.
Trinh L; Arbour-Nicitopoulos KP; Sabiston CM; Alibhai SM; Jones JM; Berry SR; Loblaw A; Faulkner GE
Oncol Nurs Forum; 2015 Jul; 42(4):398-406. PubMed ID: 26148319
[TBL] [Abstract][Full Text] [Related]
2. Perceptions of physically active men with prostate cancer on the role of physical activity in maintaining their quality of life: possible influence of androgen deprivation therapy.
Keogh JW; Patel A; MacLeod RD; Masters J
Psychooncology; 2013 Dec; 22(12):2869-75. PubMed ID: 23904113
[TBL] [Abstract][Full Text] [Related]
3. RiseTx: testing the feasibility of a web application for reducing sedentary behavior among prostate cancer survivors receiving androgen deprivation therapy.
Trinh L; Arbour-Nicitopoulos KP; Sabiston CM; Berry SR; Loblaw A; Alibhai SMH; Jones JM; Faulkner GE
Int J Behav Nutr Phys Act; 2018 Jun; 15(1):49. PubMed ID: 29880049
[TBL] [Abstract][Full Text] [Related]
4. Perceived barriers and facilitators to physical activity in men with prostate cancer: possible influence of androgen deprivation therapy.
Keogh JW; Patel A; MacLeod RD; Masters J
Eur J Cancer Care (Engl); 2014 Mar; 23(2):263-73. PubMed ID: 24134506
[TBL] [Abstract][Full Text] [Related]
5. Exercise preferences among men with prostate cancer receiving androgen-deprivation therapy.
Harrington JM; Schwenke DC; Epstein DR
Oncol Nurs Forum; 2013 Sep; 40(5):E358-67. PubMed ID: 23989028
[TBL] [Abstract][Full Text] [Related]
6. Long-term quality of life in disadvantaged men with prostate cancer on androgen-deprivation therapy.
Sevilla C; Maliski SL; Kwan L; Connor SE; Litwin MS
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):237-43. PubMed ID: 22289781
[TBL] [Abstract][Full Text] [Related]
7. Associations of light physical activity, moderate-to-vigorous physical activity and sedentary behavior with quality of life in men on androgen deprivation therapy for prostate cancer: a quantile regression analysis.
Trinh L; Alibhai SMH; Culos-Reed N; Sabiston CM; Jones JM; Rosenberg DE; Whitehorn A; Bastas D; Faulkner GE
J Behav Med; 2022 Aug; 45(4):533-543. PubMed ID: 35061159
[TBL] [Abstract][Full Text] [Related]
8. Comparing eccentric resistance exercise in prostate cancer survivors on and off hormone therapy: a pilot study.
Hansen PA; Dechet CB; Porucznik CA; LaStayo PC
PM R; 2009 Nov; 1(11):1019-24. PubMed ID: 19942188
[TBL] [Abstract][Full Text] [Related]
9. Survival outcomes in men receiving androgen-deprivation therapy as primary or salvage treatment for localized or advanced prostate cancer: 20-year single-centre experience.
DiBlasio CJ; Malcolm JB; Hammett J; Wan JY; Aleman MA; Patterson AL; Wake RW; Derweesh IH
BJU Int; 2009 Nov; 104(9):1208-14. PubMed ID: 19388987
[TBL] [Abstract][Full Text] [Related]
10. Predictors of physical activity and quality of life in New Zealand prostate cancer survivors undergoing androgen-deprivation therapy.
Keogh JW; Shepherd D; Krägeloh CU; Ryan C; Masters J; Shepherd G; MacLeod R
N Z Med J; 2010 Nov; 123(1325):20-9. PubMed ID: 21317957
[TBL] [Abstract][Full Text] [Related]
11. Resistance Exercise Reduces Body Fat and Insulin During Androgen-Deprivation Therapy for Prostate Cancer.
Winters-Stone KM; Dieckmann N; Maddalozzo GF; Bennett JA; Ryan CW; Beer TM
Oncol Nurs Forum; 2015 Jul; 42(4):348-56. PubMed ID: 26148314
[TBL] [Abstract][Full Text] [Related]
12. The lived experience of physically active older prostate cancer survivors on androgen deprivation therapy.
Wright-St Clair VA; Malcolm W; Keogh JW
Aging Male; 2014 Mar; 17(1):57-62. PubMed ID: 23862577
[TBL] [Abstract][Full Text] [Related]
13. Androgen-deprivation therapy and metabolic syndrome in men with prostate cancer.
Harrington JM; Schwenke DC; Epstein DR; Bailey DE
Oncol Nurs Forum; 2014 Jan; 41(1):21-9. PubMed ID: 24368236
[TBL] [Abstract][Full Text] [Related]
14. Exercise improves quality of life in androgen deprivation therapy-treated prostate cancer: systematic review of randomised controlled trials.
Teleni L; Chan RJ; Chan A; Isenring EA; Vela I; Inder WJ; McCarthy AL
Endocr Relat Cancer; 2016 Feb; 23(2):101-12. PubMed ID: 26584972
[TBL] [Abstract][Full Text] [Related]
15. Improving Physical and Mental Health in Patients with Prostate Cancer Undergoing Androgen Deprivation Therapy: Strategies to Promote and Improve Physical Activity Quality and Quantity.
Toohey K; McKune A; Nahon I; Kavanagh PS; Newton RU; Paterson C
Semin Oncol Nurs; 2020 Aug; 36(4):151051. PubMed ID: 32682582
[TBL] [Abstract][Full Text] [Related]
16. 'You know I've joined your club… I'm the hot flush boy': a qualitative exploration of hot flushes and night sweats in men undergoing androgen deprivation therapy for prostate cancer.
Eziefula CU; Grunfeld EA; Hunter MS
Psychooncology; 2013 Dec; 22(12):2823-30. PubMed ID: 23893467
[TBL] [Abstract][Full Text] [Related]
17. Androgen deprivation therapy: evidence-based management of side effects.
Ahmadi H; Daneshmand S
BJU Int; 2013 Apr; 111(4):543-8. PubMed ID: 23351025
[TBL] [Abstract][Full Text] [Related]
18. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
[TBL] [Abstract][Full Text] [Related]
19. Information needs of men on androgen deprivation therapy.
Soeyonggo T; Warde P; Fleshner N; Timilshina N; Alibhai SM
BJU Int; 2012 May; 109(10):1503-9. PubMed ID: 21883845
[TBL] [Abstract][Full Text] [Related]
20. Promoting general health during androgen deprivation therapy (ADT): a rapid 10-step review for your patients.
Moyad MA
Urol Oncol; 2005; 23(1):56-64. PubMed ID: 15885584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
